Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Oncología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 1 temprana
ClinicalTrials.gov
Phase 1 Suicide Plus Immune Gene Therapy for Advanced Melanoma
INTERVENTIONAL
Inicio: 20 de feb de 2020
ID: NCT03338777
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomised, Double-Blind, Placebo-Controlled, Multicentre Study Of The Efficacy And Safety Of Atezolizumab Plus Chemotherapy For Patients With Early Relapsing Recurrent (Inoperable Locally Advanced Or Metastatic) Triple-Negative Breast Cancer
INTERVENTIONAL
Inicio: 11 de ene de 2018
ID: NCT03371017
Reclutando
Fase 3
ClinicalTrials.gov
A Randomised, Open-Label, Phase III Study of Saruparib (AZD5305) Plus Camizestrant Compared With Physician's Choice CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant for the First-Line Treatment of Patients With BRCA1, BRCA2, or PALB2 Mutations and Hormone Receptor Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified) Advanced Breast Cancer (EvoPAR-Breast01)
INTERVENTIONAL
Inicio: 1 de ago de 2024
ID: NCT06380751
Reclutando
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind Study to Compare the Pharmacokinetics Between ABP 234 and Keytruda® (Pembrolizumab) in Participants With Early-stage Non-squamous Non-small Cell Lung Cancer as Adjuvant Treatment Following Resection and Platinum-based Chemotherapy
INTERVENTIONAL
Inicio: 12 de sept de 2024
ID: NCT06430866
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study
INTERVENTIONAL
Inicio: 9 de sept de 2013
ID: NCT01804686
Completado
Fase 3
ClinicalTrials.gov
A Phase III, International, Randomised, Double Blind, Parallel-Group Study to Assess the Efficacy of Zactima™ Versus Tarceva® in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer After Failure of at Least One Prior Chemotherapy
INTERVENTIONAL
Inicio: 1 de ago de 2006
ID: NCT00364351
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-blind Phase 3 Study of Amcenestrant (SAR439859) Plus Palbociclib Versus Letrozole Plus Palbociclib for the Treatment of Patients With ER (+), HER2 (-) Breast Cancer Who Have Not Received Prior Systemic Anti-cancer Treatment for Advanced Disease
INTERVENTIONAL
Inicio: 14 de oct de 2020
ID: NCT04478266
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Multicenter, Randomized, Double-blind Placebo-controlled Trial Evaluating Crofelemer for the Prophylaxis of Diarrhea in Adult Patients With Solid Tumors Receiving Targeted-cancer Therapies With or Without Standard Chemotherapy
INTERVENTIONAL
Inicio: 7 de oct de 2020
ID: NCT04538625
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized Phase 3 Double-Blinded Study Comparing the Efficacy and Safety of Niraparib to Placebo in Participants With Either HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer With Molecular Disease Based on Presence of Circulating Tumor DNA After Definitive Therapy (ZEST)
INTERVENTIONAL
Inicio: 28 de jun de 2021
ID: NCT04915755
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Comparative Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Subjects With High-Risk, Metastatic Hormone-naive Prostate Cancer (mHNPC)
INTERVENTIONAL
Inicio: 12 de feb de 2013
ID: NCT01715285
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized Open-Label Study to Compare the Pharmacokinetics, Efficacy, and Safety of Subcutaneous (SC) Trastuzumab With Intravenous (IV) Trastuzumab Administered in Women With HER2-Positive Early Breast Cancer (EBC)
INTERVENTIONAL
Inicio: 16 de oct de 2009
ID: NCT00950300
Completado
Fase 3
ClinicalTrials.gov
An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI
INTERVENTIONAL
Inicio: 1 de may de 2010
ID: NCT01104584
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Multi-centre Phase II, Double-Blind, Randomised Study of Savolitinib in Combination With Osimertinib vs Savolitinib in Combination With Placebo in Patients With EGFRm+ and MET Amplified Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed Following Treatment With Osimertinib
INTERVENTIONAL
Inicio: 28 de sept de 2020
ID: NCT04606771
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa Monoclonal Antibody, Administered Intravenously, in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy
INTERVENTIONAL
Inicio: 1 de sept de 2006
ID: NCT00361335
Retirado
Fase 4
ClinicalTrials.gov
A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors
INTERVENTIONAL
Inicio: 16 de sept de 2019
ID: NCT03988114
Retirado
Fase 3
ClinicalTrials.gov
A Phase Ib/II Safety Trial of Nivolumab in Combination With Ipilimumab Administered in Participants With Chemotherapy-naive Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) (CheckMate 955: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 955)
INTERVENTIONAL
Inicio: 9 de mar de 2018
ID: NCT03048136
Terminado
Fase 3
ClinicalTrials.gov
An Open-label, Randomized Phase 3 Study of the Efficacy and Tolerability of Linifanib (ABT-869) Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
INTERVENTIONAL
Inicio: 1 de ene de 2010
ID: NCT01009593
Completado
Fase 2
ClinicalTrials.gov
Study of Two Doses of ALIMTA (Pemetrexed) as First Line Chemotherapy for Advanced Breast Cancer
INTERVENTIONAL
Inicio: 1 de may de 2003
ID: NCT00065533
Completado
Fase 2
ClinicalTrials.gov
Prospective, Open-labelled, Phase II Study, of the Administration of Desmopressin in Patients With Colorectal Cancer, With or Without Metastasis, With Rectal Bleeding, Before Treatment With Surgery and/or Chemotherapy and/or Radiotherapy.
INTERVENTIONAL
Inicio: 1 de abr de 2013
ID: NCT01623206
Completado
Fase 3
ClinicalTrials.gov
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
INTERVENTIONAL
Inicio: 1 de mar de 2004
ID: NCT00171314
Anterior
1
...
56
57
58
...
434
Siguiente
Filtros